FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Back
Dockets Entered On November 06, 2006
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
2006N-0292 Unique Device Identification
2006N-0314 Proposal to Debar Mrs.Lawrence Kozlowski, Notice of Opportunity for Hearing
2006N-0315 Proposal to Debar Lawrence Kozlowski, Notice of Opportunity for Hearing
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
2006P-0450 Revoke approval of Allergan's supplemental NDA #21-257/S-013 for Lumigan (bimatoprost ophthalmic solution 0.03%) and deny Alcon's supplemental NDA for Travatan (travopr
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 18163 Douglas Laboratories Vol #: 167
LET 18164 Integrative Therapeutics Inc Vol #: 167
LET 18165 Perrigo Company of South Carolina Vol #: 167
LET 18166 Perrigo Company of South Carolina Vol #: 167
LET 18167 Perrigo Company of South Carolina Vol #: 167
LET 18168 Perrigo Company of South Carolina Vol #: 167
LET 18169 Perrigo Company of South Carolina Vol #: 167
LET 18170 Perrigo Company of South Carolina Vol #: 167
LET 18171 Perrigo Company of South Carolina Vol #: 167
LET 18172 Perrigo Company of South Carolina Vol #: 167
LET 18173 Perrigo Company of South Carolina Vol #: 167
LET 18174 Perrigo Company of South Carolina Vol #: 167
LET 18175 AdvoCare International LP Vol #: 167
LET 18176 PuraPharm International HK Ltd Vol #: 167
LET 18177 PuraPharm International HK Ltd Vol #: 167
LET 18178 PuraPharm International HK Ltd Vol #: 167
LET 18179 PuraPharm International HK Ltd Vol #: 167
LET 18180 PuraPharm International HK Ltd Vol #: 167
LET 18181 PuraPharm International HK Ltd Vol #: 167
LET 18182 PuraPharm International HK Ltd Vol #: 167
LET 18183 PuraPharm International HK Ltd Vol #: 167
LET 18184 PuraPharm International HK Ltd Vol #: 167
LET 18185 PuraPharm International HK Ltd Vol #: 167
LET 18186 PuraPharm International HK Ltd Vol #: 167
LET 18187 PuraPharm International HK Ltd Vol #: 167
LET 18188 PuraPharm International HK Ltd Vol #: 167
LET 18189 PuraPharm International HK Ltd Vol #: 167
LET 18190 PuraPharm International HK Ltd Vol #: 167
LET 18191 PuraPharm International HK Ltd Vol #: 167
LET 18192 PuraPharm International HK Ltd Vol #: 167
LET 18193 PuraPharm International HK Ltd Vol #: 167
LET 18194 PuraPharm International HK Ltd Vol #: 167
LET 18195 PuraPharm International HK Ltd Vol #: 167
LET 18196 PuraPharm International HK Ltd Vol #: 167
LET 18197 PuraPharm International HK Ltd Vol #: 167
LET 18198 PuraPharm International HK Ltd Vol #: 167
LET 18199 PuraPharm International HK Ltd Vol #: 167
LET 18200 PuraPharm International HK Ltd Vol #: 167
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
C 2 C. DeNardis Vol #: 1
EC 800 Mr. Dennis Klein Vol #: 4
EC 801 Dr. Anne Barbeau Gardiner Vol #: 4
EC 802 Mrs. sharon rosini Vol #: 4
EC 803 Child of GOD Vol #: 4
EC 804 Wayne County Health Department Vol #: 4
EC 805 U.S. NAVY Vol #: 4
EC 806 Mrs. Dorene Francis Vol #: 4
EC 807 Presentation Group Vol #: 4
EC 808 Mrs. Ann Lieb Vol #: 4
EC 809 Mrs. Wanda O'Brien Vol #: 4
EC 810 Mrs. Linda Robinson Vol #: 4
EC 811 n/a Vol #: 4
EC 812 Franciscans of the Immaculate Vol #: 4
EC 813 Mrs. Joan Bornemann Vol #: 4
EC 814 Mrs. Amy Nichols Vol #: 4
EC 815 Mr. John Mancuso Vol #: 4
EC 816 Mrs. Laura Mancuso Vol #: 4
EC 817 Mrs. Gaetana Sclafani Vol #: 4
EC 818 Mrs. Mary Ellen Stackel Vol #: 4
EC 819 Mrs. Roseanne Podlinsek Vol #: 4
EC 820 St. Elizabeth Medical Center Vol #: 4
EC 821 Mrs. Lana Hess Vol #: 4
EC 822 Mrs. Sandra Minihan Vol #: 4
EC 823 St. Athanasius Academy Vol #: 4
EC 824 Mrs. Deb Schmiesing Vol #: 4
EC 825 Mrs. Raven Wenner Vol #: 4
EC 826 Individual Vol #: 4
EC 827 Mr. Bryan Sheehan Vol #: 4
EC 828 Mrs. Sarah Koss Vol #: 4
EC 829 Ms. Mary King Vol #: 4
EC 830 Mrs. Karen McGraw Vol #: 4
EC 831 Mrs. Jan Caito Vol #: 4
EC 832 Mrs. jJohnnie Weaver Vol #: 4
2006N-0292 Unique Device Identification
C 1 Heath Industry Business Communications Council (HIBCC) Vol #: 1
2006N-0314 Proposal to Debar Mrs.Lawrence Kozlowski, Notice of Opportunity for Hearing
LET 1 FDA/CDER to L. Kozlowski Vol #: 1
2006N-0315 Proposal to Debar Lawrence Kozlowski, Notice of Opportunity for Hearing
LET 1 FDA/CDER to J. Kozlowski Vol #: 1
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
C 35 D. Costa Vol #: 7
C 36 M. MacFarlane Vol #: 7
2006P-0450 Revoke approval of Allergan's supplemental NDA #21-257/S-013 for Lumigan (bimatoprost ophthalmic solution 0.03%) and deny Alcon's supplemental NDA for Travatan (travopr
C 1 D. Lowe Vol #: 1

Page created on November 7, 2006 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management